Book Online Tickets for Implementing a Quality Management System, Palo Alto. 
Implementing a Quality Management System

 
 

This GLP quality system webinar provides a general overview of the Proposed Rule, a GLP QMS and its implementation, GAP analysis, Plan-Do-Check-Act cycle, process control and optimization theo

Implementing a Quality Management System

 

  • One Dial-in One Attendee

    Sale Date Ended

    USD 249
    Sold Out
  • Group-Max 10 Attendees or Location

    Sale Date Ended

    USD 629
    Sold Out
  • 1x Person - Unlimited viewing for 6 Months

    Sale Date Ended

    USD 299
    Sold Out
  • One CD or USB is for usage in one location only

    Sale Date Ended

    USD 399
    Sold Out
  • LIVE + RECORDED VERSION

    Sale Date Ended

    USD 429
    Sold Out
  • LIVE + TRAINING CD or USB

    Sale Date Ended

    USD 529
    Sold Out

Invite friends

Contact Us

Page Views : 5

About The Event

Implementing a Quality Management System

 
 
This GLP quality system webinar provides a general overview of the Proposed Rule, a GLP QMS and its implementation, GAP analysis, Plan-Do-Check-Act cycle, process control and optimization theory and quality audits are utilized for the analysis of an existing QMS and the potential benefits, barriers steps to implementing an optimized GLP QMS.

Why Should You Attend:

Medicine quality requires meeting regulations and established specifications. Quality management in pharmaceutical industries is an important subject because the products are delivered directly into the consumers body, thus identity, purity safety and ultimately appropriate quality of product are critical. Ultimately the quality of pharma products is a legal issue and must be maintained in pharmaceutical products. In today’s highly regulated and competitive environment, with many existing drugs coming off patent and delivery to market slowing, companies often forget about quality processes.

In August of 2016 the Department of Health and Human Services (HHS) of the Food and Drug Administration (FDA) submitted a proposal amending 21 CFR 58, Good Laboratory Practice for Nonclinical Laboratory studies (The Proposed Rule) in an effort to focus on quality, combat the decline in new drugs to market and standardize international requirements. One of the critical changes required by this amendment requires nonclinical laboratories to follow a complete quality management system (QMS) approach when conducting safety and toxicity studies intended to support applications and submissions to the FDA.

While this proposed amendment has not been ratified, the benefits of a clear and effective GLP QMS are proven, documented and quantifiable. A GLP QMS can provide for the alignment of FDA regulations with other existing international (OECD) and domestic (EPA) GLP regulations, the reduction of duplicative efforts and development costs, more effective compliance and resource allocation while ensuring the uniformity, consistency, reliability, quality, reproducibility and integrity of GLP study data submitted to the FDA.

Areas Covered in the Webinar:

  • GLP Regulations
  • Quality Management System (QMS)
    • Definition
    • Principles
    • Purpose
    • Function
    • Elements
  • Quality Policy
  • Quality Objectives
  • Quality Manual
  • GLP SOPs
  • Plan, Do, Check, Act Cycle
  • GAP Analysis
  • QMS Implementation Steps
  • Process Control and Optimization Theory
  • Process Criteria
  • Quality Audit

Free Materials:

  • Proposed Rule Summary
  • Cost of QMS
  • GLP QMS GAP Analysis Checklist
  • Sample GLP QMS Table of Contents
  • Example of Process Flow & Criteria
  • Required GLP SOPs
  • SOP Template
  • Seven Tools of Quality Management
  • Terms: Define & Differentiate

Who Will Benefit:

  • Senior Managers, Managers & Supervisors
  • Process Owners
  • Departmental Heads
  • Quality System, QA, QC and Continuous Improvement Managers and Personnel
  • Quality Consultants
  • Regulatory and Compliance Managers
  • Change Control/Documentation Staff

Instructor Profile:

William D Fox

William D Fox
Quality Management Professional, Texas Biomedical Research Institute

William D Fox is a quality management professional with a background in clinical research and quality assurance. William’s experience includes scientific, administrative, and quality aspects of regulated (ISO, GCP, GLP, GMP) pharmaceutical development and manufacturing and spans the translational interface (T1; late preclinical, early clinical) with a focus on oncology drug development and emerging disease vaccine development in BSL 2, 3 & 4 environments. William also has experience developing quality management systems, documents and change control systems in GLP, GCP and GMP settings.

 
 

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

 

More Events From Same Organizer

Similar Category Events